(Q40894883)

English

A humanized monoclonal antibody against respiratory syncytial virus (palivizumab) inhibits RSV-induced neurogenic-mediated inflammation in rat airways

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

A humanized monoclonal antibody against respiratory syncytial virus (palivizumab) inhibits RSV-induced neurogenic-mediated inflammation in rat airways (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

0 references

author name string

Piedimonte G

1

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

King KA

2

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Holmgren NL

3

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Bertrand PJ

4

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Rodriguez MM

5

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Hirsch RL

6

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

language of work or name

0 references

publication date

1 March 2000

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Pediatric Research

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

47

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

351-356

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

https://scigraph.springernature.com/pub.10.1203/00006450-200003000-00011

0 references

Syndrome of Periodic Fever, Aphthous stomatitis, Pharyngitis, and Adenitis (PFAPA)—What it isn’t. What is it?

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200003000-00011

21 January 2018

Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200003000-00011

21 January 2018

Tachykinin peptides, receptors, and peptidases in airway disease

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200003000-00011

21 January 2018

Neurogenic inflammation and asthma

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200003000-00011

21 January 2018

Replication-deficient adenoviral vector for gene transfer potentiates airway neurogenic inflammation.

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200003000-00011

21 January 2018

The development of monoclonal antibodies to respiratory syncytial virus and their use in diagnosis by indirect immunofluorescence

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200003000-00011

21 January 2018

Glucocorticoids inhibit neurogenic plasma extravasation and prevent virus-potentiated extravasation in the rat trachea

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200003000-00011

21 January 2018

Vascular protein leakage in various tissues induced by substance P, capsaicin, bradykinin, serotonin, histamine and by antigen challenge

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200003000-00011

21 January 2018

Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200003000-00011

21 January 2018

Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200003000-00011

21 January 2018

Some statistical methods useful in circulation research.

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200003000-00011

21 January 2018

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200003000-00011

21 January 2018

Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200003000-00011

21 January 2018

Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200003000-00011

21 January 2018

Identifiers

10.1203/00006450-200003000-00011

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40894883&oldid=1909651174"